Lisa Porter
Vermögen: - $ am 31.08.2026
Vermögen: - $ am 31.08.2026
Dr. Lisa E.
Porter, MD, is a Chief Medical Officer at Vivani Medical, Inc. She is on the Board of Directors at ViaCyte, Inc. Dr. Porter was previously employed as a Chief Medical Officer by Dance Biopharm, Inc., a Vice President-Medical Development by Amylin Pharmaceuticals, Inc., a Group Director-Metabolism by GlaxoSmithKline Plc, an Associate Medical Director by Zeneca Pharmaceuticals, a Chief Medical Officer by Eiger BioPharmaceuticals, Inc., and a Chief Medical Officer by Nano Precision Medical, Inc. She received her undergraduate degree from The College of William & Mary and a doctorate degree from Duke University School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VIVANI MEDICAL INC. -.--% | 28.07.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| VIVANI MEDICAL, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.08.2022 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Direktor/Vorstandsmitglied | 19.01.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Corporate Officer/Principal | 01.01.2013 |
| GSK PLC | Corporate Officer/Principal | 01.01.2004 |
Zeneca Pharmaceuticals
Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures medicines | Corporate Officer/Principal | - |
Nano Precision Medical, Inc.
Nano Precision Medical, Inc. Medical SpecialtiesHealth Technology Develops small sub-dermal implants with the nan portal membrane | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
Nano Precision Medical, Inc.
Nano Precision Medical, Inc. Medical SpecialtiesHealth Technology Develops small sub-dermal implants with the nan portal membrane | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The College of William & Mary
The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zeneca Pharmaceuticals
Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures medicines | Health Technology |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Health Technology |
Duke University School of Medicine
Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
Vivani Medical, Inc.
Vivani Medical, Inc. Medical SpecialtiesHealth Technology Develops small sub-dermal implants with nan portal membrane | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen